312.89
+8.61
+(2.83%)
At close: 4:00:02 PM EST
315.78
+2.89
+(0.92%)
After hours: 4:37:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
39,199,000.00
34,072,000.00
31,974,000.00
27,771,000.00
19,423,000.00
Cost of Revenue
34,534,000.00
29,738,000.00
28,048,000.00
24,491,000.00
16,746,000.00
Gross Profit
4,665,000.00
4,334,000.00
3,926,000.00
3,280,000.00
2,677,000.00
Operating Expense
3,022,000.00
2,761,000.00
2,545,000.00
2,260,000.00
1,599,000.00
Operating Income
1,643,000.00
1,573,000.00
1,381,000.00
1,020,000.00
1,078,000.00
Net Non Operating Interest Income Expense
-111,000.00
-109,000.00
-110,000.00
-120,000.00
-102,000.00
Other Income Expense
--
--
-208,000.00
-25,000.00
-15,000.00
Pretax Income
1,532,000.00
1,464,000.00
1,063,000.00
875,000.00
961,000.00
Tax Provision
388,000.00
373,000.00
271,000.00
216,000.00
288,000.00
Net Income Common Stockholders
1,144,000.00
1,091,000.00
792,000.00
659,000.00
673,000.00
Diluted NI Available to Com Stockholders
1,144,000.00
1,091,000.00
792,000.00
659,000.00
673,000.00
Basic EPS
19.78
18.71
13.66
11.36
11.35
Diluted EPS
19.66
18.71
13.55
11.25
11.23
Basic Average Shares
57,775.00
58,300.00
58,000.00
58,000.00
59,300.00
Diluted Average Shares
58,100.00
58,300.00
58,500.00
58,600.00
59,900.00
Total Operating Income as Reported
1,643,000.00
1,573,000.00
1,173,000.00
1,020,000.00
1,078,000.00
Total Expenses
37,556,000.00
32,499,000.00
30,593,000.00
26,751,000.00
18,345,000.00
Net Income from Continuing & Discontinued Operation
1,144,000.00
1,091,000.00
792,000.00
659,000.00
673,000.00
Normalized Income
1,144,000.00
1,091,000.00
946,960.00
659,000.00
673,000.00
Interest Expense
111,000.00
109,000.00
110,000.00
120,000.00
102,000.00
Net Interest Income
-111,000.00
-109,000.00
-110,000.00
-120,000.00
-102,000.00
EBIT
1,643,000.00
1,573,000.00
1,173,000.00
995,000.00
1,063,000.00
EBITDA
1,824,000.00
1,744,000.00
1,349,000.00
1,126,000.00
1,151,000.00
Reconciled Cost of Revenue
34,534,000.00
29,738,000.00
28,048,000.00
24,491,000.00
16,746,000.00
Reconciled Depreciation
181,000.00
171,000.00
176,000.00
131,000.00
88,000.00
Net Income from Continuing Operation Net Minority Interest
1,144,000.00
1,091,000.00
792,000.00
659,000.00
673,000.00
Total Unusual Items Excluding Goodwill
--
--
-208,000.00
--
76,000.00
Total Unusual Items
--
--
-208,000.00
--
76,000.00
Normalized EBITDA
1,824,000.00
1,744,000.00
1,557,000.00
1,126,000.00
1,151,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
-53,040.00
--
--
12/31/2020 - 7/2/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNC Centene Corporation
64.62
+1.11%
CI The Cigna Group
282.98
-6.70%
HUM Humana Inc.
296.91
+0.91%
ELV Elevance Health, Inc.
399.32
-0.24%
NEUE NeueHealth, Inc.
7.34
0.00%
ALHC Alignment Healthcare, Inc.
15.20
-0.78%
UNH UnitedHealth Group Incorporated
545.57
+1.39%
OSCR Oscar Health, Inc.
17.30
+3.72%
CVS CVS Health Corporation
56.82
-0.14%
CLOV Clover Health Investments, Corp.
4.4300
-0.45%